Legis Daily

Viral Gain of Function Research Moratorium Act

USA117th CongressS-3012| Senate 
| Updated: 10/19/2021
Roger Marshall

Roger Marshall

Republican Senator

Kansas

Cosponsors (10)
Joni Ernst (Republican)Tommy Tuberville (Republican)Mike Braun (Republican)Marsha Blackburn (Republican)Tom Cotton (Republican)Roger F. Wicker (Republican)Rand Paul (Republican)James Lankford (Republican)Bill Hagerty (Republican)Marco Rubio (Republican)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Viral Gain of Function Research Moratorium Act This bill prohibits the award of federal research grants to institutions of higher education or research institutes that conduct gain-of-function research. Gain-of-function research refers to any research that (1) may be reasonably anticipated to confer attributes to influenza, MERS, or SARS viruses such that the virus would have enhanced pathogenicity or transmissibility in an organism; or (2) involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 19, 2021
Introduced in Senate
Oct 19, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • October 19, 2021
    Introduced in Senate


  • October 19, 2021
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Education programs fundingHealth programs administration and fundingHigher educationInfectious and parasitic diseasesMedical researchResearch administration and funding

Viral Gain of Function Research Moratorium Act

USA117th CongressS-3012| Senate 
| Updated: 10/19/2021
Viral Gain of Function Research Moratorium Act This bill prohibits the award of federal research grants to institutions of higher education or research institutes that conduct gain-of-function research. Gain-of-function research refers to any research that (1) may be reasonably anticipated to confer attributes to influenza, MERS, or SARS viruses such that the virus would have enhanced pathogenicity or transmissibility in an organism; or (2) involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 19, 2021
Introduced in Senate
Oct 19, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • October 19, 2021
    Introduced in Senate


  • October 19, 2021
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roger Marshall

Roger Marshall

Republican Senator

Kansas

Cosponsors (10)
Joni Ernst (Republican)Tommy Tuberville (Republican)Mike Braun (Republican)Marsha Blackburn (Republican)Tom Cotton (Republican)Roger F. Wicker (Republican)Rand Paul (Republican)James Lankford (Republican)Bill Hagerty (Republican)Marco Rubio (Republican)

Health, Education, Labor, and Pensions Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Education programs fundingHealth programs administration and fundingHigher educationInfectious and parasitic diseasesMedical researchResearch administration and funding